psoriasis

crown royalty king queen win
Biotech

J&J's IL-23 drug defeats Sotyktu in phase 3 psoriasis trial

After being touted as a rival to BMS’ reigning psoriasis med Sotyktu for months, J&J’s IL-23 drug looks like it has a shot at taking the crown.
James Waldron Sep 17, 2025 9:45am
An arrow incrementally going up stairs before pointing straight up Blue background

Junshi sees ph. 3 psoriasis win for IL-17 drug, preps China push

Sep 8, 2025 4:54am
Shanghai China at sunrise

Fosun rises again, beaming up 3rd biotech deal in 3 weeks

Aug 29, 2025 10:05am
reshuffle pipeline target reorganize shift change

Lilly shakes up pain pipeline as part of quarterly R&D clearout

Aug 7, 2025 8:28am
Vine jungle rainforest

Vyne prunes psoriasis trial, but keeps faith in BET inhibitor

Jul 2, 2025 10:33am
business targets illustration

Accropeutics' TYK2/JAK1 inhibitor scores phase 2 psoriasis win

May 21, 2025 6:25am